Select language:

Dostarlimab Cost in India
Dostarlimab-gxly injection in India is used to treat endometrial cancer (cancer of the uterine or womb lining) in patients whose cancer has returned, spread, or cannot be removed surgically. It is also used to treat a specific type of solid tumor that has spread to other parts of the body in adults who have previously failed to respond to another chemotherapy medication and have no other treatment options. India is one of the nations with the lowest prices for Dostarlimab Injection when compared to other developed nations. The doctor’s expertise and the cutting-edge medical technology employed in Indian hospitals may…
Read More

    By submitting the form I agree to the Terms and Conditions and Privacy Policy of MedSurge India.

    How Should This Medication Be Given? Dostarlimab-gxly injection is a solution (liquid) that a doctor or nurse will inject intravenously (into a vein) over 30 minutes in a medical facility or infusion center. It is usually given once every three weeks for four cycles, and then once every six weeks…
    Read More
    The Most Important Frequently Asked Questions

    Q: How Many Dostarlimab Doses Are Required?

    A: The recommended monotherapy dose is 500 mg dostarlimab every 3 weeks for four cycles, followed by 1000 mg every 6 weeks for all subsequent cycles.

    Q: Is Dostarlimab Effective Against All Cancers?

    A: Dostarlimab is currently only approved by the FDA to treat mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer and dMMR solid tumors.

    Q: Dostarlimab Treats What Types of Cancer?

    A: Dostarlimab, an anti-programmed cell death protein (PD-1) monoclonal antibody, has mesmerised the medical profession by showing complete (100%) cure of patients with colorectal cancer in an era of rapid development.

    Q: Can Dostarlimab Be Used to Treat Lymphoma?

    A: According to experts, the cancer cannot be detected through physical examination, endoscopy, positron emission tomography (PET) scans, or MRI scans. This demonstrates Dostarlimab’s potential as a “possible” cancer cure for one of the most lethal tumors.

    Q: What Is the Mechanism of Action of Dostarlimab?

    A: Dostarlimab inhibits the PD-1 pathway, which may aid your immune system in identifying and capturing tumour cells. Giving niraparib with dostarlimab may be more effective against the tumour and maximise tumour shrinkage before surgery.


    Top Doctors

    Start your Journey to Good Health With Medsurge India

    Trusted by Patients from Across the World

    10,000+ Patients Assisted

    From 50+ Countries

    400+ Top Hospitals and Clinics

    1500+ Specialized Doctors

      By submitting the form I agree to the Terms and Conditions and Privacy Policy of MedSurge India.

      By using our site, you agree to our Terms and Conditions and Privacy Policy. Medsurgeindia does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.

      © Copyright 2023 NSM ONLINE SOLUTIONS PRIVATE LIMITED. All rights reserved.

      Made with ♥️ in Bharat
      Enquire Us